Summary

Dr. Matthew Gallitto is an Assistant Professor of Radiation Oncology and Director of Proton Therapy Services at Columbia University Irving Medical Center. He received his undergraduate degree in Biology with highest honors from New York University, medical degree from the Icahn School of Medicine at Mount Sinai, and PhD from Columbia University Graduate School of Arts and Sciences. He completed his residency training at Columbia University Irving Medical Center, where he served as Chief Resident. Dr. Gallitto is active in NRG Oncology, American Society for Radiation Oncology (ASTRO), and Children's Oncology Group (COG). His clinical interests focus on pediatric and brain cancers. He leads a laboratory focusing on the identification of therapies that synergize with radiation therapy as well as novel methods to overcome the blood-brain barrier to treat pediatric brain cancer. He is an ASCO Young Investigator Award and NIH/NCI Paul Calabresi Career Development Award recipient.

Office Location

CUIMC/Presbyterian Hospital and Vanderbilt Clinic

622 West 168th StreetNew York, NY 10032

Quick Facts

  • accepting new patients
  • 7 years of experience
  • 21 insurance plans accepted
  • Icahn School Of Medicine At Mount Sinai
  • 2 specialties
  • 2 areas of expertise
  • 1 hospital affiliation
  • 1 office location
  • Male

Insurance Plans Accepted by Dr. Matthew R Gallitto

  • Accepts Medicare
  • Accepts Medicaid
  • Aetna
  • Affinity Health Plan
  • Amida Care
  • Cigna
  • ElderServe
  • Emblem/GHI
  • Emblem/Hip
  • Empire Blue Cross Blue Shield Healthplus
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Healthfirst
  • Healthspring (Cigna Medicare)
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • UnitedHealthcare
  • VNSNY CHOICE
  • Wellcare
  • World Trade Center Health Plan

Medical Specialties

Dr. Matthew R Gallitto has the following 2 specialties

Specialty Expertise

Dr. Matthew R Gallitto has the following 2 areas of expertise

  • Internal Medicine
  • Radiation Oncologist

Certifications, License, & Education

7 Years Experience

Dr. Matthew R Gallitto holds an active medical license in the states of New York and New Jersey.

Medical License

Medical Doctor with an active medical license in the state of New York that expires in 2027 and an active medical license in the state of New Jersey that expires in 2027.

Education & Training

Medical School

Graduated from Icahn School Of Medicine At Mount Sinai in 2019.

NPI Number

Dr. Gallitto's NPI number is 1396204616.

Other Providers at NewYork-Presbyterian

Frequently Asked Questions

Is Dr. Matthew Gallitto accepting new patients?
Dr. Matthew Gallitto is accepting new patients on Vitals. View Dr. Matthew Gallitto's profile on Vitals to make an appointment.
Does Dr. Matthew Gallitto accept my insurance?
You can see the insurance plans that Dr. Matthew Gallitto accepts on their Vitals profile.
How can I make an appointment with Dr. Matthew Gallitto?
You can find contact information for Dr. Matthew Gallitto here on Vitals.
Which hospitals is Dr. Matthew Gallitto affiliated with?
Dr. Matthew Gallitto is affiliated with Newyork Presbyterian Columbia University Irving Medical Center.
Where is Dr. Matthew Gallitto's office located?
Dr. Matthew Gallitto's office is located at 622 West 168th Street, New York, NY, 10032.

Ensuring Data Transparency and Trust: A Guide to Vitals Doctor Listings and Reviews

Our provider data is gathered directly from physicians and publicly available databases. Providers who verify their profiles gain the ability to update information, offering additional details about their specialties,education, treated conditions, performed procedures, and accepted insurances.

Reviews on Vitals are submitted by users only. Recognizing the valuable insights these reviews offer into a doctor's reputation, we maintain internal policies and protocols to ensure the quality and accuracy of all reviews. Importantly, providers cannot delete or alter reviews independently. Reviews can only be deleted or changed following an internal assessment by our customer service team.

Your feedback is highly valued and we encourage you to contact our support team should you encounter any issues.